Optimization of antitumor effect of liposomally encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling (Q78199005)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469906%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

title

Optimization of antitumor effect of liposomally encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469906%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

1 reference

1 reference

H Harashima

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469906%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

S Iida

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469906%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Y Urakami

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469906%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

M Tsuchihashi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469906%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

H Kiwada

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469906%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469906%20AND%20SRC:MED&resulttype=core&format=json

Journal of Controlled Release

12 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469906%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469906%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469906%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

93-106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469906%20AND%20SRC:MED&resulttype=core&format=json

Sterically stabilized liposomes

12 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration--time product.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Evaluation of the efficiency of targeting of antitumor drugs: simulation analysis based on pharmacokinetic/pharmacodynamic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Clinical pharmacokinetics-pharmacodynamics of anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

A pharmacokinetic analysis program (multi) for microcomputer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

A nonlinear least squares program based on differential equations, MULTI (RUNGE), for microcomputers.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Comparison of free and liposome encapsulated doxorubicin tumor drug uptake and antitumor efficacy in the SC115 murine mammary tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Kinetic analysis of AUC-dependent saturable clearance of liposomes: mathematical description of AUC dependency.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Residence time distributions of various tracers in tumors: implications for drug delivery and blood flow measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Doxorubicin weekly low dose administration: in vitro cytotoxicity generated by the typical pharmacokinetic profile

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Prediction of the plasma concentration time courses of various drugs in humans based on data from rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Pharmacodynamics of Chemotherapeutic Effects: Dose-Time-Response Relationships for Phase-Nonspecific Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Prediction of the maximal tolerated dose (MTD) and therapeutic effect of anticancer drugs in humans: integration of pharmacokinetics with pharmacodynamics and toxicodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Dependence of the cytostatic effect of adriamycin on drug concentration and exposure time in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Pharmacokinetic analysis of drug disposition after intratumoral injection in a tissue-isolated tumor perfusion system.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Endocytosis does not necessarily augment the cytotoxicity of adriamycin encapsulated in immunoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

A clinicopathologic analysis of adriamycin cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Doxorubicin: effect of different schedules on toxicity and anti-tumor efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

Kinetic analysis of tissue distribution of doxorubicin incorporated in liposomes in rats (II).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900110-8

7 January 2021

10.1016/S0168-3659(99)00110-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469906%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference